Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland.

Pan Q, Rosenthal DT, Bao L, Kleer CG, Merajver SD.

Clin Cancer Res. 2009 Dec 1;15(23):7441-6. doi: 10.1158/1078-0432.CCR-09-1361. Epub 2009 Nov 24.

2.

Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer.

Brewer GJ.

Curr Cancer Drug Targets. 2005 May;5(3):195-202. Review.

PMID:
15892619
3.

Immunobiology of her-2/neu transgenic mice.

Pannellini T, Forni G, Musiani P.

Breast Dis. 2004;20:33-42. Review.

PMID:
15687705
4.

Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice.

Calogero RA, Cordero F, Forni G, Cavallo F.

Breast Cancer Res. 2007;9(4):211. Review.

Supplemental Content

Support Center